AstraZeneca acquires former Amgen LakeCentre facility, planning up to 400 jobs

AstraZeneca – AstraZeneca today added to its biologics manufacturing capability in the US with the purchase of a high-tech biologics bulk manufacturing facility from Amgen Inc. Keep reading